期刊文献+

膀胱移行细胞癌患者预后因素的多元分析 被引量:4

Multivariable analysis of survival in patients with tran-sitional cell bladder carcinoma
原文传递
导出
摘要 作者对82例膀胱移行细胞癌患者的肿瘤分级、浸润程度、肿瘤大小、部位、数量、基部形态、手术方式及年龄8个因素与预后的关系进行了探讨。在单因素分析中,除年龄和手术方式外,其它各因素均与预后密切相关;在多因素分析中发现组织学分级是最重要的预后指标,其次为肿瘤的发生部位和浸润深度,其它因素统计学差异无显著性。作者认为不应忽视肿瘤部位对患者预后的影响。 AbstractIn 82 transitional cell bladder cancer patients withadequate follow-up,the prognostic value of histologi-cal grade,depth of invasion,size,site,appearance,number of primary tumours,surgical treatment andages of patients were assessed.Univariable analysisshowed the statistically significant relation of histologi-cal grade,depth of invasion,size,site,appearance andnumber of turnours to survival.Survival analysis withCox's regression model Indicated that the histologicalgrade is the most important prognostic factor,followedby site of tumours and depth of invasion.The resultssuggest that the information of site should not be omit-ted.
出处 《中华外科杂志》 CAS CSCD 北大核心 1995年第6期353-354,共2页 Chinese Journal of Surgery
  • 相关文献

参考文献1

  • 1骆福添,中国卫生统计,1988年,4卷,59页

同被引文献27

  • 1刘积良,段寅,隋捷.髂内动脉结扎灌注或化学栓塞治疗晚期盆腔恶性肿瘤[J].中国肿瘤临床,1995,22(3):168-170. 被引量:17
  • 2石红林,李启忠.动脉序贯化疗预防浸润性膀胱癌术后复发23例[J].肿瘤研究与临床,2007,19(2):120-121. 被引量:1
  • 3张元芳 王忠.膀胱肿瘤[A].见:汤钊猷主编.现代肿瘤学:第2版[C].上海:上海医科大学出版社,2000.1182.
  • 4李长青.泌尿系统肿瘤[A].见:刘泰福主编.现代放射肿瘤学[C].上海:复旦大学出版社,2001.295-304.
  • 5LAMM DL. Prophylaxis for recmxent transitional cell carcinoma [J]. Urology, 1991, 37(Suppl 5): 21-23.
  • 6FORD JM, HAIT WN. Pharmacology of drugs that alter mul- tidrug resistance in cancer[J]. Pharmocol Rev, 1990, 42(3): 155- 199.
  • 7BELLIVEAU JF, POSNER MR, FERRARIL, et al. Cisplatinad- nainisteredasacontinuouss-dayinfusion: plasmaplat inuousleveisan- durineexeretion[J]. Cancev Tveat Rep, 1986, 70: 1215-1217.
  • 8LEHANE DE. Intra-arterial cisplatinum in advanced solid tu- mors. In: Howell SB, ed. Intra-arterial and intracavitary cancer chemotherapy[M]. Boston: Martinus Nijhoff, 1984: 1-10.
  • 9JACOBS SC, MMEASHE DS, MEWISSEN MW, et al. Intraar- terial cisplatin infu 2 sion in the management of transitional cell carcinoma of the bladder[J]. Can 2 cer, 1989, 64: 388-391.
  • 10TSUKARNOTO S, ISHIKAWA S, TSUTSUNI M, et al. An or- gan-sparing treatment using intra-arterial chemotherapy and ra- diotherapy for muscle-invading bladder carcinoma[J]. Scand J Urol Nephrol, 2002, 36: 339-343.

引证文献4

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部